Huisheng Biotech: Net profit attributable to shareholders of listed companies in 2023 was 19.5 million yuan to 25 million yuan, down 52.57% to 63.00% from the same period last year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.